Is Nantworks publicly traded?
Is Nantworks publicly traded?
NantWorks LLC founded in 2007 with headquarters in Culver City, California is an American multinational conglomerate holding company….NantWorks.
| Type | Public |
|---|---|
| Website | nantworks.com |
What is Patrick Soon Shiong net worth?
9 billion USD (2021)
Patrick Soon-Shiong/Net worth
Who owns Nant capital?
billionaire Patrick Soon-Shiong
New York-based Highbridge Capital Management and Culver City-based Nant Capital have agreed to provide financing through convertible notes due in 2026. Nant Capital is controlled by billionaire Patrick Soon-Shiong, who is also NantHealth’s majority shareholder.
Where is NantHealth located?
Where are NantHealth headquarters? The headquarters for NantHealth are in 2240 E Mariposa Ave El Segundo, CA 90245.
How many employees does NantWorks have?
How many employees does NantWorks have? NantWorks has 1,001 to 5,000 employees.
Who owns Immunitybio?
NantWorks
ImmunityBio/Parent organizations
Who is the richest doctor in the world?
As the richest doctor on earth, Patrick Soon Shiong is a doctor turned entrepreneur turned philanthropist who is worth close to $12 billion. He made his fortune transforming cancer treatments.
Who is the richest engineer in the world?
Jeff Bezos Net worth: $176.4 billion He launched a telecommunication company called Fitel, He is also the founder of Amazon, Inc. Mr. Bezos spent time working as a technical engineer for a company called D.E. Shaw & Co. He is the richest engineer in the world as of 2021.
What is NantHealth?
NantHealth empowers the creation of integrated healthcare delivery networks. In developing technology that supports systems and data, we enable efficiency, personalized treatment, and collaboration across health care.
Who owns LA Times?
Patrick Soon-Shiong
Against this backdrop the paper’s staff voted to unionize in January 2018. The following month Tronc announced that it was selling the Los Angeles Times to Patrick Soon-Shiong, a local biotech billionaire, for $500 million. As part of the deal, he also agreed to purchase the San Diego Union-Tribune.
Is NantKwest a good investment?
If you are looking for stocks with good return, NantKwest Inc can be a profitable investment option. With a 5-year investment, the revenue is expected to be around +356.07%.
What company is NK?
NantKwest (NASDAQ: NK) is an innovative, clinical-stage, immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf natural killer (NK) cell therapies.
What kind of company is Nantworks LLC?
NantWorks LLC founded in 2007 with headquarters in Culver City, California is an American multinational conglomerate holding company. It owns a number of technology companies in the fields of healthcare, commerce, digital entertainment as well as a venture capital firm in the healthcare, education, science, and technology sectors.
When did NantHealth Inc report its earnings results?
NantHealth Inc (NASDAQ:NH) issued its earnings results on Friday, February, 28th. The company reported ($0.04) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.02. The business had revenue of $24.19 million for the quarter, compared to analyst estimates of $23.10 million.
Who is the CEO of NantHealth Inc.?
82 employees have rated NantHealth CEO Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among NantHealth’s employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
Who are the insiders of NantHealth, Inc?
NH stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Geode Capital Management LLC, Squarepoint Ops LLC, BlackRock Inc., Nuveen Asset Management LLC, and Barclays PLC. View insider buying and selling activity for NantHealth or or view top insider-buying stocks.
